MKI67 and astrocytoma (excluding glioblastoma): In a study of 33 WHO grade II astrocytomas by Yue et al. [15], expression of Ki-67 was significantly associated with malignant progression, suggesting that tumors expressing higher Ki-67 may have an inherently faster growth rate and thus recur faster in the setting of gross-total or subtotal resection.